A detailed history of Valley National Advisers Inc transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Valley National Advisers Inc holds 2,265 shares of DGX stock, worth $310,508. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,265
Previous 3,535 35.93%
Holding current value
$310,508
Previous $482,000 27.18%
% of portfolio
0.06%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$137.09 - $137.09 $174,104 - $174,104
-1,270 Reduced 35.93%
2,265 $351,000
Q2 2024

Jul 18, 2024

SELL
$125.91 - $144.34 $23,545 - $26,991
-187 Reduced 5.02%
3,535 $482,000
Q1 2024

Apr 19, 2024

SELL
$123.78 - $142.11 $51,740 - $59,401
-418 Reduced 10.1%
3,722 $494,000
Q4 2023

Jan 25, 2024

SELL
$120.62 - $141.12 $21,108 - $24,696
-175 Reduced 4.06%
4,140 $569,000
Q3 2023

Nov 13, 2023

SELL
$121.86 - $144.92 $74,212 - $88,256
-609 Reduced 12.37%
4,315 $526,000
Q2 2023

Jul 31, 2023

SELL
$130.56 - $146.84 $11,880 - $13,362
-91 Reduced 1.81%
4,924 $693,000
Q1 2023

Apr 26, 2023

BUY
$131.53 - $155.76 $13,942 - $16,510
106 Added 2.16%
5,015 $735,000
Q4 2022

Jan 12, 2023

SELL
$123.31 - $157.26 $9,988 - $12,738
-81 Reduced 1.62%
4,909 $750,000
Q3 2022

Nov 08, 2022

SELL
$121.77 - $141.1 $16,560 - $19,189
-136 Reduced 2.65%
4,990 $647,000
Q2 2022

Jul 15, 2022

SELL
$127.07 - $145.39 $381 - $436
-3 Reduced 0.06%
5,126 $696,000
Q1 2022

May 06, 2022

BUY
$129.09 - $164.35 $662,102 - $842,951
5,129 New
5,129 $702,000
Q1 2019

Apr 26, 2019

SELL
$80.68 - $89.92 $2,823 - $3,147
-35 Closed
0 $0
Q4 2018

Feb 25, 2019

BUY
$79.75 - $108.38 $2,791 - $3,793
35 New
35 $3,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.